- Home
- NPFD vs EBS Comparison
NPFD vs EBS Comparison
Compare NPFD & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NPFD | EBS |
|---|---|---|
| Founded | 2021 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 459.8M | 625.0M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | NPFD | EBS |
|---|---|---|
| Price | $19.07 | $12.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 64.7K | ★ 864.9K |
| Earning Date | 01-01-0001 | 10-29-2025 |
| Dividend Yield | ★ 6.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.35 |
| Revenue | N/A | ★ $788,900,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.21 |
| P/E Ratio | ★ N/A | $9.48 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.50 | $4.02 |
| 52 Week High | $18.07 | $13.41 |
Technical Indicators
Market Signals| Indicator | NPFD | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 33.92 | 63.98 |
| Support Level | $19.00 | $12.06 |
| Resistance Level | $19.15 | $12.95 |
| Average True Range (ATR) | 0.15 | 0.54 |
| MACD | -0.04 | 0.06 |
| Stochastic Oscillator | 10.00 | 80.39 |
Price Performance
Historical ComparisonAbout NPFD Nuveen Variable Rate Preferred & Income Fund
Nuveen Variable Rate Preferred&Income is a diversified, closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The fund invests a majority of its assets in variable-rate preferred securities and other variable-rate income-producing securities. The rest of its investments can be made in contingent capital securities or contingent convertible securities, convertible securities, corporate debt securities, U.S. government securities, residential and commercial mortgage-backed securities, fixed-rate preferred securities, senior loans and loan participations and assignments, sovereign debt instruments, debt securities issued by supranational agencies, and/or taxable and tax-exempt municipal bonds.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.